Full Lineage Multi-Species Primary Neural Cells Officially Launched: Cloud-Clone Establishes Core Raw Material Advantages for Neuroscience and Regenerative Medicine
KATY, TX / 500NewsWire / July 27, 2026 / A long-standing industry bottleneck plagues central nervous system (CNS) drug development: approximately 92% to 96% of candidate drugs that succeed in animal studies ultimately fail human clinical trials. The poor predictive performance of traditional research models creates a costly translational gap across neuroscience research. To bridge this divide, researchers…
